Patent Assignment
Reel/Frame 058480/0221
Partial Release of Security Interest
Recorded: 2021-12-10
Pages: 10
Assignor
BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Executed: 2021-12-01
Assignees
BIOMAT USA, INC.
2410 LILLYVALE AVENUE, LOS ANGELES, CALIFORNIA, 90032-3514
TALECRIS PLASMA RESOURCES, INC.
2410 LILLYVALE AVENUE, LOS ANGELES, CALIFORNIA, 90032-3514
Covered Properties
(50)
Poly(Alkylene Oxide)-Factor Viii or Factor Ix Conjugate
Patent:
6,037,452 →
Application:
07/866,518 →
Preparation of Alpha-1-Antichymotrypsin
Patent:
5,561,108 →
Application:
08/282,860 →
Low Temperature Albumin Fractionation Using Sodium Caprylate as a Partitioning Agent
Patent:
5,561,115 →
Application:
08/288,180 →
Purification of Alpha-1 Proteinase Inhibitor Using Novel Chromatographic Separation Conditions
Patent:
5,610,285 →
Application:
08/295,119 →
Peptide Ligands Which Bind to Von Willebrand Factor
Patent:
5,688,912 →
Application:
08/537,069 →
Anion Exchange Process for the Purification of Factor Viii
Patent:
5,659,017 →
Application:
08/554,724 →
Fibrinogen Binding Peptides
Patent:
5,723,579 →
Application:
08/595,718 →
Manufacturing Process for the Production of Purified Transferrin
Patent:
5,744,586 →
Application:
08/668,351 →
Peptides Which Bind to Prothrombin and Thrombin
Patent:
5,831,003 →
Application:
08/672,805 →
Method and Device for Delivering Fibrin Glue
Patent:
5,844,087 →
Application:
08/744,488 →
Method and Device for Mechanical Testing of Fibrin Glue Strength
Patent:
5,911,165 →
Application:
08/864,797 →
Peptide Ligands for Affinity Purification of Fibrinogen
Patent:
5,783,663 →
Application:
09/012,343 →
Alpha-1 Proteinase Inhibitor Binding Peptides
Patent:
5,985,836 →
Application:
09/127,574 →
Method and Device for Delivering Fibrin Glue
Patent:
6,121,422 →
Application:
09/200,636 →
Manufacturing Method for Intraveneously Administrable Immune Globulin and Resultant Product
Patent:
6,162,904 →
Application:
09/421,405 →
Method of Thrombolysis by Local Delivery of Active Plasmin
Patent:
6,355,243 →
Application:
09/438,331 →
Method of Preparing Alpha-1 Proteinase Inhibitor
Patent:
6,462,180 →
Application:
09/449,695 →
Process for Viral Inactivation of Lyophilized Blood Proteins
Method of Thrombolysis by Local Delivery of Reversibly Inactivated Acidified Plasmin
Method of Thrombolysis by Local Delivery of Reversibly Inactivated Acidified Plasmin
Method for Melting Frozen, Water-Containing Products in a Mixer
Process for the Production of a Reversibly Inactive Acidified Plasmin Composition
Recombinantly Modified Plasmin
Recombinant Plasmin for Opthalmic Indications
Method of Treatment and Prophylaxis of Diseases Related to Amyloid Deposition Using Igm
Reversibly Inactivated Acidified Plasmin
Composition and Method for Preparing Plasminogen
Method, Composition, and Article of Manufacture for Providing Alpha-1 Antitrypsin
Application:
12/741,030 →
Publication:
US 2011/0002909
Method for Adjusting Results of a Polymerase Chain Reaction (Pcr) Instrument
Recombinantly Modified Plasmin
Two-Stage Ultrafiltration/Diafiltration
Composition, Method, and Kit for Preparing Plasmin
Compositions, Methods and Kits for Preparing Plasminogen and Plasmin Prepared Therefrom
Recombinantly Modified Plasmin
Device for Maintaining Sterile Integrity of Connected Fluid Pathways
Recombinantly Modified Plasmin
Recombinantly Modified Plasmin
Von Willebrand Factor (Vwf)-Containing Preparations, and Methods, Kits, and Uses Related Thereto
Lyophilization Methods, Compositions, and Kits
Therapeutic Delivery Devices, Systems, and Methods
Reversibly Inactivated Acidified Plasmin Composition
Immunochromatography Devices, Methods and Kits
Method for Detection of Parvovirus B19
Methods, Compositions, and Kits for Determining Human Immunodeficiency Virus (Hiv)
Methods, Compositions, and Kits for Determining Human Immunodeficiency Virus (Hiv)
Compositions, Methods, and Kits for Nucleic Acid Hybridization
Human Erythrovirus
Patent:
9,598,739 →
Application:
14/288,691 →
Two-Stage Ultrafiltration/Diafiltration
Immunochromatography Devices, Methods, and Kits
Composition, Method, and Kit for Alpha-1 Proteinase Inhibitor
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Jun 3, 2011
From: GRIFOLS, S.A.; GRIFOLS INC.; TALECRIS BIOTHERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 026390/0193 →
Change of Name
Jun 18, 2013
From: TALECRIS BIOTHERAPEUTICS, INC.
To: GRIFOLS THERAPEUTICS INC.
Reel/Frame 030650/0819 →
Security Agreement
Feb 27, 2014
From: GRIFOLS INC.; GRIFOLS THERAPEUTICS INC.; GRIFOLS-CHIRON DIAGNOSTICS CORP.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032367/0001 →
Assignment of Assignor's Interest
Jan 11, 2017
From: GRIFOLS, S.A.
To: GRIFOLS THERAPEUTICS INC.
Reel/Frame 040941/0366 →
Release of Security Interest Recorded at Reel/Frame 26390/0193
Jan 25, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: GRIFOLS, S.A.; GRIFOLS INC.; TALECRIS BIOTHERAPEUTICS, INC.
Reel/Frame 041494/0017 →
Release of Security Interest
Feb 6, 2017
From: DEUTSCHE BANK AG NEW YORK BRANK
To: GRIFOLS THERAPEUTICS INC.; GRIFOLS SHARED SERVICES NORTH AMERICA INC.; GRIFOLS DIAGNOSTIC SOLUTIONS INC.
Reel/Frame 041638/0527 →
Security Interest
Feb 7, 2017
From: GRIFOLS SHARED SERVICES NORTH AMERICA INC.; GRIFOLS THERAPEUTICS INC.; GRIFOLS BIOLOGICALS INC.; BIOMAT USA, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 041651/0487 →
Security Interest
Dec 5, 2017
From: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.; GRIFOLS THERAPEUTICS INC.; GRIFOLS BIOLOGICALS INC.; BIOMAT USA, INC.
To: EUROPEAN INVESTMENT BANK, AS LENDER
Reel/Frame 044696/0846 →
Security Interest
Dec 5, 2017
From: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.; GRIFOLS THERAPEUTICS INC.; GRIFOLS BIOLOGICALS INC.; BIOMAT USA, INC.
To: EUROPEAN INVESTMENT BANK, AS LENDER
Reel/Frame 044697/0725 →
Change of Name
Jan 5, 2018
From: GRIFOLS THERAPEUTICS INC.
To: GRIFOLS THERAPEUTICS LLC
Reel/Frame 045008/0573 →
Change of Address
Jun 1, 2018
From: GRIFOLS THERAPEUTICS LLC
To: GRIFOLS THERAPEUTICS LLC
Reel/Frame 046286/0824 →
Security Interest
Sep 7, 2018
From: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.; GRIFOLS THERAPEUTICS LLC; GRIFOLS BIOLOGICALS LLC; BIOMAT USA, INC.
To: EUROPEAN INVESTMENT BANK, AS LENDER
Reel/Frame 047438/0836 →
Security Interest
Nov 15, 2019
From: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.; GRIFOLS THERAPEUTICS LLC; GRIFOLS BIOLOGICALS LLC; BIOMAT USA, INC.
To: EUROPEAN INVESTMENT BANK
Reel/Frame 051024/0453 →
Release of Security Interest
Nov 15, 2019
From: EUROPEAN INVESTMENT BANK
To: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.; GRIFOLS THERAPEUTICS LLC (FORMERLY KNOWN AS GRIFOLS THERAPEUTICS, INC.; GRIFOLS BIOLOGICALS LLC (FORMERLY KNOWN AS GRIFOLS BIOLOGICALS, INC.); BIOMAT USA, INC.
Reel/Frame 051064/0021 →
Release of Security Interest
Nov 15, 2019
From: EUROPEAN INVESTMENT BANK
To: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.; GRIFOLS THERAPEUTICS LLC (FORMERLY KNOWN AS GRIFOLS THERAPEUTICS, INC.); GRIFOLS BIOLOGICALS LLC (FORMERLY KNOWN AS GRIFOLS BIOLOGICALS, INC.); BIOMAT USA, INC.
Reel/Frame 051024/0722 →
Security Interest
Nov 15, 2019
From: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.; GRIFOLS THERAPEUTICS LLC; GRIFOLS BIOLOGICALS LLC; BIOMAT USA, INC.
To: EUROPEAN INVESTMENT BANK
Reel/Frame 051021/0593 →
Security Interest
Nov 15, 2019
From: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.; GRIFOLS THERAPEUTICS LLC; GRIFOLS BIOLOGICALS LLC; BIOMAT USA, INC.
To: EUROPEAN INVESTMENT BANK
Reel/Frame 051024/0317 →
Security Interest
Nov 18, 2019
From: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.; GRIFOLS THERAPEUTICS LLC; GRIFOLS BIOLOGICALS LLC; BIOMAT USA, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 051047/0123 →
Security Interest
Nov 18, 2019
From: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.; GRIFOLS THERAPEUTICS LLC; GRIFOLS BIOLOGICALS LLC; BIOMAT USA, INC.
To: THE BANK OF NEW YORK MELLON, LONDON BRANCH, AS NOTES COLLATERAL AGENT
Reel/Frame 051047/0139 →
Release of Security Interest
Nov 18, 2019
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.; GRIFOLS THERAPEUTICS LLC (FORMERLY KNOWN AS GRIFOLS THERAPEUTICS, INC.); GRIFOLS BIOLOGICALS LLC (FORMERLY KNOWN AS GRIFOLS BIOLOGICALS, INC.); BIOMAT USA, INC.
Reel/Frame 051047/0153 →
Partial Release of Security Interest in Patents at Reel/Frame No. 51047/0139
Dec 1, 2021
From: THE BANK OF NEW YORK MELLON, LONDON BRANCH
To: BIOMAT USA, INC.; TALECRIS PLASMA RESOURCES, INC.
Reel/Frame 058292/0564 →
Partial Release of Security Interest in Patents at Reel/Frame No. 51024/0317
Dec 7, 2021
From: EUROPEAN INVESTMENT BANK
To: BIOMAT USA, INC.; TALECRIS PLASMA RESOURCES, INC.
Reel/Frame 058518/0524 →
Partial Release of Security Interest in Patents at Reel/Frame No. 51021/0593
Dec 7, 2021
From: EUROPEAN INVESTMENT BANK
To: BIOMAT USA, INC.; TALECRIS PLASMA RESOURCES, INC.
Reel/Frame 058350/0980 →
Partial Release of Security Interest in Patents at Reel/Frame No. 51024/0453
Dec 7, 2021
From: EUROPEAN INVESTMENT BANK
To: BIOMAT USA, INC.; TALECRIS PLASMA RESOURCES, INC.
Reel/Frame 058351/0064 →
Security Interest
May 14, 2024
From: GRIFOLS SHARED SERVICES NORTH AMERICA, INC.; GRIFOLS THERAPEUTICS LLC; GRIFOLS BIOLOGICALS LLC; GRIFOLS WORLDWIDE OPERATIONS USA, INC.
To: THE BANK OF NEW YORK MELLON, LONDON BRANCH
Reel/Frame 067409/0127 →